- Contact Information
- Subscribe to these events
- Send to a Friend
- Send to Social Media outlet
- Cancer Community News Home
- 12 views
Technologies for Cancer Immunotherapies
Dr. James R. Heath, professor of chemistry at CalTech, spoke at the Pioneers in Bioengineering Lecture Series today. Dr. Heath presented the talk "Technologies for Personalizing Cancer Immunotherapies."
To a packed room, Dr. Heath talked about cancer immunotherapies and their interactions between the principle cancer cell killers, T cells, and antigens presented by the tumor cells. During his talk Dr. Heath explored how those interactions may be exposed through the use of checkpoint inhibitors, or they can be amplified through the use of engineered cell-based therapies. He discussed his lab's approaches and shared an analysis of cancer patient materials representing multiple tumor types.
About the speaker:
Jim Heath is the Elizabeth Gilloon Professor and Professor of Chemistry at Caltech, and co-leads the Cancer Nanotechnology Program within the JCCC. He has directed the National Cancer Institute funded NSB Cancer Center since 2005, which is a NCI-funded Cancer Center for Nanotechnology Excellence that is a joint Caltech/UCLA program focused on translating new therapeutic and diagnostic technologies from benchtop to bedside. Heath also co-Directs the UCLA Parker Institute for Cancer Immunotherapy. He received his PhD from Rice University. He was a member of the research staff at IBM Watson Labs before joining the faculty at UCLA in 1994, and then moving to Caltech in 2003. Heath’s group works on the development and application of single cell and molecular methods for fundamental cancer biology and translational oncology applications.
Heath group website http://www.its.caltech.edu/~heathgrp/